Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
02/2003
02/06/2003WO2001064717A9 Novel therapeutic treatment of chronic obstructive pulmonary disease
02/06/2003WO2001047946A3 GFRα1-RET SPECIFIC AGONISTS AND METHODS THEREFOR
02/06/2003US20030028923 Nucleotide sequences coding enzymatic polypeptide for use in the generation of disease resistant plants
02/06/2003US20030028913 Generation of antibody with preferential binding activity; obtain plant, transform with nucleotide sequences coding immunoglobulin, express nucleotide sequences, recover imunoglobulin
02/06/2003US20030028910 Animal model for use in the diagnosis and treatment dietetics
02/06/2003US20030028907 Nucleotide sequences coding polypeptide for use in human therapeutics and diagnostics
02/06/2003US20030028905 Mutant forms of the TGF-beta type II receptor which bind all TGF-beta isoforms
02/06/2003US20030028904 Genes involved in engulfment of dying cells and cell migration
02/06/2003US20030028888 Systems and methods for providing consumers with entertainment content and associated periodically updated advertising
02/06/2003US20030028140 Cross-linked gelatin composition comprising a wetting agent
02/06/2003US20030028089 Diabetes management system
02/06/2003US20030028009 Polypeptide for use in the treatment of arthritis, psoriasis, cancer, inflammation, and diabetic retinopathy
02/06/2003US20030028008 Nucleotide sequences coding polypeptide for use in the treatment of urogenital, tumor, antherosclerotic and kidney disorders
02/06/2003US20030028007 Vascular endothelial growth factor 2
02/06/2003US20030028006 Cytokine receptor common gamma chain like
02/06/2003US20030028005 Mammalian proteins; related reagents and methods
02/06/2003US20030028003 Nucleotide sequences codng polypeptide for use in the treatment, diagnosis and prevention inflammation and cancer
02/06/2003US20030027999 143 human secreted proteins
02/06/2003US20030027998 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cardiovascular, nervous system, cancer and infectious disorders
02/06/2003US20030027995 Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
02/06/2003US20030027993 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/06/2003US20030027992 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/06/2003US20030027990 Mammalian CX3C chemokine genes
02/06/2003US20030027989 Nucleotide seq uences coding polypeptide for use in the diagnosis and treatment of cancer
02/06/2003US20030027987 Novel polypeptide from Haemophilus paragallinarum and process for preparing the same
02/06/2003US20030027986 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/06/2003US20030027985 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/06/2003US20030027983 Transport protein for use in the treatment of blood, hypertensive and epileptic disorders
02/06/2003US20030027981 Urokinase-type plasminogen activator receptor
02/06/2003US20030027979 Peptide for use in the treatment of infections of the urogenital systems
02/06/2003US20030027850 Compounds which inhibit leukocyte adhesion mediated by VLA-4
02/06/2003US20030027819 Administering to an animal in need for protease inhibition an effective amount of substituted heterobicyclic compound containing amino acid side chains
02/06/2003US20030027807 Vitronectin receptor antagonists, their preparation and their use
02/06/2003US20030027783 Introducing into the cell an RNA comprising a double stranded structure having nucleotide sequence which is substantially identical to part of target gene and which is derived from an endogenous template; verifying inhibition of expression
02/06/2003US20030027782 Method for treating allergic lung disease
02/06/2003US20030027781 Contacting mixture of nucleic acid sequences with blood brain barrier or CSF-blood barrier tissue; partitioning increased affinity nucleic acids from candidate mixture; amplifying increased to yield a mixture of nucleic acids
02/06/2003US20030027774 For diagnosis and therapy of tuberculosis
02/06/2003US20030027771 For therapy of inflammatory condition is selected from asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, multiple sclerosis, rheumatoid arthritis, tissue transplantation, tumor metastasis
02/06/2003US20030027770 Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof
02/06/2003US20030027769 For inhibiting angiogenesis
02/06/2003US20030027768 For therapy of diseases and conditions mediated by undesired and uncontrolled cell invasion and/or angiogenesis
02/06/2003US20030027767 To cause apoptosis in colon cancer and prostate cancer cells
02/06/2003US20030027766 Used in cancer therapy and production of potential anti-cancer vaccines
02/06/2003US20030027765 Therapeutic peptides having a motif that binds specifically to non-acetylated H3 and H4 histones for cancer therapy
02/06/2003US20030027764 Novel therapeutic and prophylactic agents and methods of using same
02/06/2003US20030027763 Contacting compound that modulates mast cell degranulation with CD43 polypeptide; determining the functional effect of the compound upon the CD43 polypeptide
02/06/2003US20030027762 Administering BPI protein product effective to alleviate the BPI deficiency
02/06/2003US20030027761 For enhancing drug delivery; wound healing; adhesion of foreign tissue implanted within a mammal; inducing apoptosis in a JAM-expressing cell
02/06/2003US20030027760 Composition and methods to improve neural outcome
02/06/2003US20030027759 Method of using PON-1 to decrease atheroma formation
02/06/2003US20030027758 Methods of treating intestinal ischemia using heparin-binding epidermal growth factor
02/06/2003US20030027757 Novel molecules of the PYRIN/NBS/LRR protein family and uses thereof
02/06/2003US20030027756 Combining a SAK polypeptide or fragment thereof with a Chk2 polypeptide and the compound, determining the binding of the SAK polypeptide or fragment thereof to Chk2 for identifying a compound capable of interfering with binding of a SAK
02/06/2003US20030027755 Compositions and methods for the rescue of white matter
02/06/2003US20030027754 As pharmaceuticals, diagnostics, biosensors and bioreactors
02/06/2003US20030027753 Bone stimulating factor
02/06/2003US20030027752 Leucine-based motif and clostridial neurotoxins
02/06/2003US20030027751 For promoting angiogenesis, bone growth, wound healing
02/06/2003US20030027749 For use in therapy, and diagnostic assays
02/06/2003US20030027748 For therapy of diabetes
02/06/2003US20030027747 For administering high levels of plant antioxidants to human and mammals; therapy of diseases
02/06/2003US20030027746 Useful in the development of human therapeutics and diagnostic formulations
02/06/2003US20030027743 Tripeptidylpeptidase inhibitors
02/06/2003US20030027658 Golf shaft with adjustable stiffness and frequency
02/06/2003US20030027358 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR)
02/06/2003US20030027337 Sequence-specific DNA recombination in eukaryotic cells
02/06/2003US20030027323 Novel human G-protein coupled receptor, HGPRBMY5, expressed highly in brain and ovarian tissues
02/06/2003US20030027318 Cytostatic factor
02/06/2003US20030027317 Enzymatic polypeptide for use as tool in the treatment of viral diseases
02/06/2003US20030027314 Extension of a protein-protein interaction surface to inactivate the function of a cellular protein
02/06/2003US20030027311 Recombinant anti-tumor RNAse
02/06/2003US20030027308 Novel human protein phosphatases identified from genomic sequencing
02/06/2003US20030027304 Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor
02/06/2003US20030027301 Nucleotide sequences coding polypeptide for use in human therapeutics, diagnostics and pharmacogenomics
02/06/2003US20030027299 Biochemical conjugate for use in the treatment or prevention of stroke, heart defect, veinous thrombosis, sepsis and embolism
02/06/2003US20030027297 19 human secreted proteins
02/06/2003US20030027284 Tumor necrosis factor-gamma
02/06/2003US20030027283 Protein l and hybrid proteins thereof
02/06/2003US20030027282 Quiescent cell dipeptidyl peptidase: a novel cytoplasmic serine protease
02/06/2003US20030027268 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/06/2003US20030027261 Novel genes TZap7/A, TZap7/B and TZap7 involved in T cell activation and uses thereof
02/06/2003US20030027260 Nucleotide sequences coding polypeptide for use in the prevention of fungal infection
02/06/2003US20030027259 Nucleotide sequences coding polypeptide for use in the treatment of alzheimer's disease
02/06/2003US20030027254 Nucleotide sequences coding protein for use in the treatment of alzheimer's disease
02/06/2003US20030027252 Novel receptors
02/06/2003US20030027250 Methods and compositions for use in spliceosome mediated RNA trans-splicing
02/06/2003US20030027248 Human cDNAs and proteins and uses thereof
02/06/2003US20030027237 Serine-threonine phosphatase protein of a parasitic organism of the apicomplexa phylum, applications in therapeutics
02/06/2003US20030027230 Detection of antiproliferative agents for treatment of ovarian cancer; obtain cells, incubate with modulator, monitor cells for reduction in cancer activity, reduction in cancer activity indicates antiproliferative agents
02/06/2003US20030027228 Detection of antiproliferative agents; obtain tumor cells, incubate with antiproliferative agent, monitor reduction in cancer activity
02/06/2003US20030027218 Peptides promoting the activation of latent tgf-beta and method for screening tgf-beta activity regulators
02/06/2003US20030027217 Diarylsulfonylurea binding proteins
02/06/2003US20030027212 Antibody for use in tissue classification
02/06/2003US20030027211 Fetuin-MGP-mineral complex in serum
02/06/2003US20030027198 Nucleotide sequences coding polypeptide for use in the treatment of tumors
02/06/2003US20030027188 SLC7s as modifiers of the p53 pathway and methods of use
02/06/2003US20030027184 Detection of preferential aptamer in sample; generate oligonucleotide, incubate with primer and polymerase, amplify and recover nucleotide sequences
02/06/2003US20030027177 Human DNA mismatch repair proteins
02/06/2003US20030027166 Nucleotide sequences coding polypeptides for use in the treatment of tumors
02/06/2003US20030027165 Nucleotide sequences sequences coding polypeptide for use in the treatment and diagnosis of autoimmune, cancer and apoptosis diseases
1 ... 1909 1910 1911 1912 1913 1914 1915 1916 1917 1918 1919 1920 1921 1922 1923 1924 1925 1926 1927 1928 1929 ... 3163